These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 26013807)

  • 1. Absence of aryl hydrocarbon receptors increases endogenous kynurenic acid levels and protects mouse brain against excitotoxic insult and oxidative stress.
    García-Lara L; Pérez-Severiano F; González-Esquivel D; Elizondo G; Segovia J
    J Neurosci Res; 2015 Sep; 93(9):1423-33. PubMed ID: 26013807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease.
    Sapko MT; Guidetti P; Yu P; Tagle DA; Pellicciari R; Schwarcz R
    Exp Neurol; 2006 Jan; 197(1):31-40. PubMed ID: 16099455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
    Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-kynurenine/aryl hydrocarbon receptor pathway mediates brain damage after experimental stroke.
    Cuartero MI; Ballesteros I; de la Parra J; Harkin AL; Abautret-Daly A; Sherwin E; Fernández-Salguero P; Corbí AL; Lizasoain I; Moro MA
    Circulation; 2014 Dec; 130(23):2040-51. PubMed ID: 25359166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
    Guidetti P; Wu HQ; Schwarcz R
    Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
    Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
    Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain.
    Mazarei G; Budac DP; Lu G; Lee H; Möller T; Leavitt BR
    Exp Neurol; 2013 Nov; 249():144-8. PubMed ID: 23994717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenine metabolism in Alzheimer's disease.
    Baran H; Jellinger K; Deecke L
    J Neural Transm (Vienna); 1999; 106(2):165-81. PubMed ID: 10226937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum.
    Amori L; Wu HQ; Marinozzi M; Pellicciari R; Guidetti P; Schwarcz R
    Neuroscience; 2009 Mar; 159(1):196-203. PubMed ID: 19138730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kynurenic acid metabolism in the brain of HIV-1 infected patients.
    Baran H; Hainfellner JA; Kepplinger B; Mazal PR; Schmid H; Budka H
    J Neural Transm (Vienna); 2000; 107(10):1127-38. PubMed ID: 11129102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tryptophan metabolite, kynurenine, promotes mast cell activation through aryl hydrocarbon receptor.
    Kawasaki H; Chang HW; Tseng HC; Hsu SC; Yang SJ; Hung CH; Zhou Y; Huang SK
    Allergy; 2014 Apr; 69(4):445-52. PubMed ID: 24397465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.
    Sekine A; Kuroki Y; Urata T; Mori N; Fukuwatari T
    Neurochem Res; 2016 Sep; 41(9):2256-66. PubMed ID: 27161376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Tryptophan-Derived AhR Ligands, Kynurenine, Kynurenic Acid and FICZ, on Proliferation, Cell Cycle Regulation and Cell Death of Melanoma Cells-In Vitro Studies.
    Walczak K; Langner E; Makuch-Kocka A; Szelest M; Szalast K; Marciniak S; Plech T
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient mice.
    Yu P; Di Prospero NA; Sapko MT; Cai T; Chen A; Melendez-Ferro M; Du F; Whetsell WO; Guidetti P; Schwarcz R; Tagle DA
    Mol Cell Biol; 2004 Aug; 24(16):6919-30. PubMed ID: 15282294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The kynurenic acid hypothesis - a new look at etiopathogenesis and treatment of schizophrenia].
    Flis M; Szymona K; Morylowska-Topolska J; Urbańska A; Krukow P; Kandefer-Szerszeń M; Zdzisińska B; Urbańska EM; Karakuła-Juchnowicz H
    Pol Merkur Lekarski; 2016 Sep; 41(243):160-164. PubMed ID: 27755520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease.
    Beaumont V; Mrzljak L; Dijkman U; Freije R; Heins M; Rassoulpour A; Tombaugh G; Gelman S; Bradaia A; Steidl E; Gleyzes M; Heikkinen T; Lehtimäki K; Puoliväli J; Kontkanen O; Javier RM; Neagoe I; Deisemann H; Winkler D; Ebneth A; Khetarpal V; Toledo-Sherman L; Dominguez C; Park LC; Munoz-Sanjuan I
    Exp Neurol; 2016 Aug; 282():99-118. PubMed ID: 27163548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kynurenic acid and kynurenine aminotransferase in heart.
    Baran H; Amann G; Lubec B; Lubec G
    Pediatr Res; 1997 Mar; 41(3):404-10. PubMed ID: 9078543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrolysin lowers kynurenic acid formation--an in vitro study.
    Baran H; Kepplinger B
    Eur Neuropsychopharmacol; 2009 Mar; 19(3):161-8. PubMed ID: 19008081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of [5-(3)H]kynurenine in the developing rat brain in vivo: effect of intrastriatal ibotenate injections.
    Ceresoli G; Guidetti P; Schwarcz R
    Brain Res Dev Brain Res; 1997 May; 100(1):73-81. PubMed ID: 9174248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenic Acid/AhR Signaling at the Junction of Inflammation and Cardiovascular Diseases.
    Grishanova AY; Perepechaeva ML
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.